4th Quarter - Report
THE D MAJOR GROUP for ALLERGAN INC (FORMERLY ACTAVIS INC )
Firm
Income
$50,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to FDA draft guidance and scientific data review, including HR 2029, the Consolidated Appropriations Act of 2016.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Analyst for the Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for the House Republican Conference |
Copyright/Patent/Trademark CPT
Issues concerning patent reform, including H.R. 9 The Innovation Act, and S. 1137, the Protecting American Talent and Entrepreneurship Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.